Funicular Funds, LP Reports New 5.2% Stake in Nasus Pharma Ltd (NSRX)

On April 7, 2026, Funicular Funds, LP, along with its general partner Cable Car Capital, LP and managing member Jacob Ma-Weaver, filed a Schedule 13G disclosing a new 5.2% ownership stake in Nasus Pharma Ltd (NSRX). The reporting persons collectively hold 612,913 ordinary shares of the issuer. This filing marks an increase from a previously reported 0.0% position, crossing the 5% beneficial ownership threshold as of the event date on March 31, 2026. The shares are held directly by Funicular Funds, LP, while Cable Car Capital, LP and Jacob Ma-Weaver may be deemed to share beneficial ownership due to their management roles. The ownership percentage is calculated based on 11,710,808 ordinary shares outstanding, as reported by the issuer in late March 2026. The filing was made under Rule 13d-1(c), certifying that the securities were acquired in the ordinary course of business and not for the purpose of influencing or changing the control of the issuer.